NUVISAN The Science CRO
Ulrike Scheib is a Business Development Manager at Nuvisan since September 2020. Prior to this, Ulrike worked as a Research Scientist at Bayer from November 2018 to September 2020. Ulrike also has experience as a Scientist at Max Planck Institutes Tübingen, where the focus was on the modulation of ligand binding interactions of periplasmic proteins PotF & PotD. Ulrike holds a PhD in Biophysics from Humboldt-Universität zu Berlin, and has previous education in Biochemistry from UC San Diego, University of Tübingen, and Universidad de Guadalajara.
This person is not in the org chart
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.